Raffles Medical Group Ltd's stock price surged 3.92% during intraday trading on Monday. The significant upward movement followed the release of the company's full-year financial results for 2025 and a proposed dividend.

The healthcare provider reported robust financial performance, with profit after tax and minority interests climbing 13.4% year-on-year to S$70.6 million. This was driven by stronger contributions from its hospital and insurance operations, as well as fair-value gains on investment properties. Group revenue inched up 1.8% to S$765.3 million, with Hospital Services leading growth with a 3.5% increase in turnover.

Furthermore, the board proposed a final cash dividend of 3.0 Singapore cents per share, representing approximately 84% of sustainable profit. The positive earnings report and shareholder return announcement appear to have bolstered investor confidence, contributing to the stock's notable gain during the trading session.